Zu "2070015-14-2" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Atovaquone-d4
Artikelnummer: TGM-T19198-10mg
Description: Atovaquone D4 is the deuterium-labeled Atovaquone. Atovaquone is a medication used to treat or prevent pneumocystis babesia, malaria, toxoplasmosis, and pneumonia. Smiles: O=C1C(=C(O)C(=O)C=2C1=C(C(=C(C2[2H])[2H])[2H])[2H])[C@H]3CC[C@@H](CC3)C4=CC=C(Cl)C=C4. References: Looareesuwan, S., et al.,...
| Anwendung: | GC-MS, LC-MS, internal standard, quantification, reversible MAO-B inhibitor |
| CAS | 2070015-14-2 |
| MW: | 370.86 D |
ab 383,00 €
Atovaquone-d4
Artikelnummer: Cay28491-1
Atovaquone-d4 is intended for use as an internal standard for the quantification of atovaquone (Cay-23802) by GC- or LC-MS. Atovaquone is a broad-spectrum antiprotozoal agent that is active against Plasmodium, Toxoplasma, and Babesia, among other protozoa. It inhibits complex III activity on dihydroorotate in...
| Schlagworte: | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione-5,6,7,8-d4 |
| Anwendung: | GC-MS, LC-MS, Internal standard, Quantification, Reversible MAO-B inhibitor |
| CAS | 2070015-14-2 |
| MW: | 370.9 D |
731,00 €
